Tools

LEADER 02245cam 2200481 a 4500

001 ocn752431958;

003 OCoLC;

005 20110915070449.0;

006 m d f ;

007 cr m||||||||||;

008 110915s2011 dcua ob f000 0 eng c;

040 a| GPOc| GPOd| MvI;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 0546-D (online);

086 0 a| GA 1.13:GAO-11-365;

088 a| GAO-11-365;

110 1 a| United States.b| Government Accountability Office.=| ^A580995;

245 10 a| End-stage renal disease :b| CMS should assess adequacy of payment when certain oral drugs are included and ensure availability of quality monitoring data : report to congressional committees.;

246 3 a| End stage renal disease :b| Centers for Medicare & Medicaid Services should assess adequacy of payment when certain oral drugs are included and ensure availability of quality monitoring data;

246 30 a| CMS should assess adequacy of payment when certain oral drugs are included and ensure availability of quality monitoring data;

246 17 a| Oral end-stage renal disease drugs;

260 a| [Washington, D.C.] :b| U.S. Govt. Accountability Office,c| [2011];

300 a| 1 online resource (ii, 39 p.) :b| ill.;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| Title from PDF title screen (viewed Sept. 12, 2011).;

500 a| "March 2011.";

504 a| Includes bibliographical references.;

500 a| "GAO-11-365.";

500 a| GPO Cataloging Record Distribution Program (CRDP).;

650 0 a| Oral medicationx| Economic aspectsz| United States.=| ^A837510;

650 0 a| Hemodialysisx| Patientsx| Economic aspects.=| ^A372348;

610 20 a| Centers for Medicare & Medicaid Services (U.S.)x| Rules and practice.=| ^A503728;

650 0 a| Medicarex| Economic aspects.=| ^A6515;

856 40 u| https://purl.fdlp.gov/GPO/gpo12609;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 2589264;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 2589264-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 10/14/2011x| EDOCUMENTz| JERESOURCE;

End-stage renal disease : CMS should assess adequacy of payment when certain oral drugs are included and ensure availability of quality monitoring data : report to congressional committees.

Author/creator	United States
Format	Electronic
Publication Info	[Washington, D.C.] : U.S. Govt. Accountability Office, [2011]
Description	1 online resource (ii, 39 p.) : ill.
Supplemental Content	https://purl.fdlp.gov/GPO/gpo12609
Subjects	Centers for Medicare & Medicaid Services (U.S.)--Rules and practice. Oral medication--Economic aspects. --United States. Hemodialysis--Patients. --Economic aspects. Hemodialysis--Patients. --Medical care. --Government policy. --United States. Medicare--Economic aspects.

Variant title	End stage renal disease : Centers for Medicare & Medicaid Services should assess adequacy of payment when certain oral drugs are included and ensure availability of quality monitoring data
Portion of title	CMS should assess adequacy of payment when certain oral drugs are included and ensure availability of quality monitoring data
Running title	Oral end-stage renal disease drugs
General note	Title from PDF title screen (viewed Sept. 12, 2011).
General note	"March 2011."
General note	"GAO-11-365."
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Technical rpt number	GAO-11-365
GPO item number	0546-D (online)
Govt. docs number	GA 1.13:GAO-11-365

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

End-stage renal disease : CMS should assess adequacy of payment when certain oral drugs are included and ensure availability of quality monitoring data : report to congressional committees.

Click here for more information about this title

Availability